Iowa Health Center COVID-19 Survey Summary Report

Latest data from January 14, 2022

Number of Health Center respondents = 11 (79% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 6,601
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) 55.72%
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 2,463
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) 61.47%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, Antigen)2 Patients Tested Positive, Virus Detection (PCR, Antigen)2
White, Non-Hispanic/Latino Patients 42.02% 36.83%
White, Hispanic/Latino Patients 29.30% 30.69%
Black/African American, Non-Hispanic/Latino Patients 9.83% 11.45%
Black/African American, Hispanic/Latino Patients 0.59% 3.78%
Asian Patients3 2.55% 3.00%
American Indian/Alaska Native Patients3 1.38% 0.73%
Native Hawaiian/Other Pacific Islander Patients3 2.61% 2.11%
Patients with More Than One Race3 2.14% 1.91%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 4.50% 5.08%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.97% 0.73%
Unreported/Refused to Report Race and Ethnicity 4.12% 3.69%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 434
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 70.24%
COVID-19 Immunization Series Completed 404
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 69.21%
COVID-19 Immunization Series Additional 708
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 50.94%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 28.11% 29.95% 47.74%
White, Hispanic/Latino Patients 27.19% 29.46% 15.25%
Black/African American, Non-Hispanic/Latino Patients 18.43% 19.55% 14.12%
Black/African American, Hispanic/Latino Patients 1.84% 0.50% 0.00%
Asian Patients3 5.76% 7.18% 8.47%
American Indian/Alaska Native Patients3 3.23% 0.99% 0.56%
Native Hawaiian/Other Pacific Islander Patients3 1.38% 2.23% 4.10%
Patients with More Than One Race3 2.07% 1.24% 1.13%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 6.45% 6.19% 5.93%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 1.61% 0.00% 0.14%
Unreported/Refused to Report Race and Ethnicity 3.92% 2.72% 2.54%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)

Metrics Value
Less Than 1 Hour 9.09%
1 to 24 Hours 27.27%
More Than 24 Hours 63.64%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 9.09%
Staffing to administer the vaccine 18.18%
Vaccine confidence 0.00%
Vaccine storage capacity 0.00%
Vaccine supply 0.00%
Other 0.00%
None 81.82%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 27.27%
Average Percent of Health Center Visits Conducted Virtually 10.45%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 27.27%
Number of Mobile Van Sites 0
Number of Pop-up Clinics 0
Number of School-Based Vaccination Sites 1
Number of Family Vaccination Clinics 4

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 0.00%
Refer patients to another organization that provides monoclonal antibody therapies 63.64%
None 36.36%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 9.09%
Patient awareness/education 9.09%
Staffing capacity 18.18%
Therapy administration/onsite logistics 18.18%
Other 9.09%
None 63.64%

Test Kit Distribution

Metrics Value
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 1
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 240

Test Kit Distribution Methods4

Metrics Value
Provide to Existing Health Center Patients 100.00%
Provide to General Public Who Came to the Health Center 100.00%
Provide at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 0.00%
Provide at Other Community Events 0.00%
Provide through direct outreach to specific populations (i.e., individuals experiencing homelessness, MSAWs, residents of public housing, individuals with limited English proficiency) 100.00%
Other 0.00%

Oral Antiviral Medication Distribution

Metrics Value
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 0
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication5 -

Oral Antiviral Medication Distribution by Race and Ethnicity5

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients -
White, Hispanic/Latino Patients -
Black/African American, Non-Hispanic/Latino Patients -
Black/African American, Hispanic/Latino Patients -
Asian Patients3 -
American Indian/Alaska Native Patients3 -
Native Hawaiian/Other Pacific Islander Patients3 -
Patients with More Than One Race3 -
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) -
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) -
Unreported/Refused to Report Race and Ethnicity -

Oral Antiviral Medication Distribution by Special/Vulnerable Population5

Metrics Value
Migratory/Agricultural Workers -
Patients Experiencing Homelessness -
Patients Who Are Residents of Public Housing -
Patients with Limited English Proficiency -
Children Under 18 Years of Age -

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

5 Percentages are calculated using the number of health centers that have distributed courses of COVID-19 oral antiviral medication received through the HRSA Health Center COVID-19 Therapeutics Program as the denominator.

Date Last Reviewed:  January 2022